Caris Life Sciences is expanding in Irving, adding 115,000 square feet of research and development and office space while creating 500 new job opportunities.
Caris Life Sciences Park will allow the company to expand beyond their work in blood-based diagnostics and molecular profiling. The new facility’s first phase should be complete in early 2020, and will include future laboratories and corporate office space. The last two phases will include additional lab space for the molecular science innovators.
“Our new facilities in Irving, Texas will allow us to add to our team of experts, and enhance our ability to deliver more insights to physicians and drug developers that will improve and save lives,” said David D. Halbert, Chairman and Chief Executive Officer of Caris Life Sciences via release.
The park will add to Caris complexes in Phoenix, recently acquired Pharmatech in Denver, and Basel Switzerland. The new facilities will total 300,000 square feet, increasing their footprint by more than 200 percent. The real estate expansion is matched by Caris’ increased workforce, which has more than doubled recenlty, totaling 700 MDs, PhDs, and researchers.
“We are pioneers in molecular science with a long history of driving revolutionary change and innovation in precision medicine,” said Michael Halbert, Senior Vice President, Human Resources via release. “Caris continues to thrive because of this strategic vision and our expansion will ensure that every patient has access to the most advanced cancer care.”
